Actively Recruiting
Randomized Double-Blind Study Comparing Ketamine and Fentanyl for Pain Relief in Adults With Traumatic Injury and Compensated Shock Before Hospital Arrival
Led by Jason Sperry · Updated on 2026-03-09
994
Participants Needed
11
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating pain management in prehospital trauma patients who have compensated shock, defined by specific heart rate or shock index criteria, and require pain treatment. This Phase 3, randomized, double-blind clinical trial aims to compare outcomes after administering ketamine hydrochloride versus fentanyl citrate before arrival at trauma centers. The trial will enroll about 994 patients over three years at select sites in the LITES Network. Participants receive either ketamine hydrochloride 2.5 mgml or fentanyl citrate 10 mcgml via slow intravenous push over about two minutes. Pain is assessed every 15 minutes after dosing, with possible redosing if pain scores remain high and no contraindications exist. Both treatments are provided in blinded, pre-filled syringes. The study focuses on prehospital care and monitoring through hospital arrival and beyond. During the study, researchers will monitor pain levels, adverse events, need for airway management, mortality within 24 hours, opioid use, and long-term outcomes including pain and opioid use up to six months after trauma. Assessments include pain scales at arrival and during hospital stay, ICU and ventilator-free days, and screening for anxiety and PTSD. Safety and survival to discharge are also tracked, with participation lasting through hospital discharge and follow-up visits up to six months.
CONDITIONS
Brief Title
Prehospital Analgesia INtervention Trial (PAIN)
Research Team
J
Jason Sperry, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here